An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product
Part of paid clinical trials in Teaneck, New Jersey.
- Sponsor
- Good Molecules, LLC
- Study ID
- NCT07136766
- Phase
- PHASE3
- Status
- Enrolling By Invitation
Conditions
- Hyperpigmentation
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Facial Toner — DRUGBrightening Toner
- Placebo Toner — OTHERPlacebo Control Toner
Study Details
The purpose of this study is to assess the efficacy (ability to produce a desired or intended result) of a topical product (applied to the skin) to improve skin lightness, skin condition and appearance (hyperpigmentation \[dark spots\], brightness/radiance \[healthy vibrant appearance\], skin texture \[smoothness\]) on \] the face over a period of eighteen (18) weeks. The data collected may support the company in developing marketing claims for its product.
Key Dates
- Start date
- Sep 10, 2025
- Status verified
- Aug 2025
- Primary completion
- Feb 16, 2026
- Completion
- Feb 16, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Test Product
- Sham Comparator: Control Product
Primary Outcome Measure
Skin Lightness [ Time Frame: 18 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Validated Claim Support | Teaneck | New Jersey | 07666 | - |
Find similar trials in Teaneck, NJ
By research site
Related Studies
- Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of ColorRecruiting · Albert Einstein College of Medicine · Elmsford, New York